Logo for Castle Biosciences Inc

Castle Biosciences Investor Relations Material

Latest events

Logo for Castle Biosciences Inc

Q1 2024

Castle Biosciences
Logo for Castle Biosciences

Q1 2024

2 May, 2024
Logo for Castle Biosciences

Q4 2023

28 Feb, 2024
Access the full event backlog
Slides, Transcripts, and Reports from 9,000+ public companies

Latest reports from Castle Biosciences Inc

Access all reports
Segment Data
Access more data
Net revenue by
Business area
Dermatologic
Other
Expenses by
Financials
Castle Biosciences, Inc., a commercial-stage dermatological cancer company, focuses to provide diagnostic and prognostic solutions for dermatological cancers. Castle Biosciences is a provider of products that assesses the response of cancer patients to treatment. The company's products include Immunoscore non-invasive test, which measures changes in proteins expressed on the surface of a person's tumor; CastleTRAC, a diagnostic tool for assessing the tissue response in four types of cutaneous T-cell lymphomas (CTCL); and CastleMAP for measuring the immune reaction to a specific drug. Castle Biosciences, Inc., is based in Friendswood, Texas.